MediciNova Inc. (MNOV) Soars 5.66% on January 11

MediciNova Inc. (MNOV) Soars 5.66% on January 11

MediciNova Inc. (MNOV) had a good day on the market for Friday January 11 as shares jumped 5.66% to close at $9.70. About 54,898 shares traded hands on 689 trades for the day, compared with an average daily volume of n/a shares out of a total float of 41.88 million. After opening the trading day at $9.10, shares of MediciNova Inc. stayed within a range of $9.70 to $9.10.

With today’s gains, MediciNova Inc. now has a market cap of $406.25 million. Shares of MediciNova Inc. have been trading within a range of $14.50 and $6.87 over the last year, and it had a 50-day SMA of $n/a and a 200-day SMA of $n/a.

MediciNova Inc is a biopharmaceutical company. It acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm’s current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases. It has the acquisition and development of small molecule therapeutics segment.

MediciNova Inc. is based out of La Jolla, CA and has some 9 employees. Its CEO is Yuichi Iwaki.

error: Content is protected !!